https://www.gov.uk/government/publications/notifiable-diseases-causative-agents-reports-for-2024/noids-causative-agents-week-2-week-ending-14-january-2024<\/a><\/p>The Department commissions research through the National Institute for Health and Care Research (NIHR). As the largest public funder for health and care research, the NIHR welcomes funding applications for research into any aspect of human health, including cures and treatments for HUS.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"}
}
, "answeringMemberConstituency" : {"_value" : "Lewes"}
, "answeringMemberPrinted" : {"_value" : "Maria Caulfield"}
, "dateOfAnswer" : {"_value" : "2024-01-29", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-01-29T16:15:58.81Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-01-19", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Haemolytic Uraemic Syndrome"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the paper in Epidemiology and Infection 2023; 151: e160, entitled Haemolytic uraemic syndrome in children England, Wales, Northern Ireland, and Ireland: A prospective cohort study, published on 1 September 2023, if she will take steps to publish more accurate data on the number of cases of Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome identified by the UK Health Security Agency; and if her Department will take steps to increase funding for research into (a) cures and (b) treatments to improve long-term health outcomes for this illness.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/178", "label" : {"_value" : "Biography information for John McDonnell"}
}
, "tablingMemberConstituency" : {"_value" : "Hayes and Harlington"}
, "tablingMemberPrinted" : [{"_value" : "John McDonnell"}
], "uin" : "10583"}
, {"_about" : "http://data.parliament.uk/resources/1683600", "AnsweringBody" : [{"_value" : "Cabinet Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1683600/answer", "answerText" : {"_value" : "
The Government remains committed to ending the systemic use of hotels, and we do not plan to open new hotels to meet the increased demand from new arrivals from Afghanistan.<\/p>
The information requested on hotel contracts is not publicly available; however, a small number of hotels with existing contracts have been extended for a limited time period to help accommodate Afghan Citizens Resettlement Scheme <\/strong>arrivals who have yet to be matched to settled housing solutions in the United Kingdom.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4485", "label" : {"_value" : "Biography information for Johnny Mercer"}
}
, "answeringMemberConstituency" : {"_value" : "Plymouth, Moor View"}
, "answeringMemberPrinted" : {"_value" : "Johnny Mercer"}
, "dateOfAnswer" : {"_value" : "2024-01-24", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-01-24T17:06:44.997Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "53"}
, "answeringDeptShortName" : {"_value" : "Cabinet Office"}
, "answeringDeptSortName" : {"_value" : "Cabinet Office"}
, "date" : {"_value" : "2024-01-19", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Refugees: Afghanistan"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Minister for the Cabinet Office, with reference to the oral contribution of the Minister for Veterans\u2019 Affairs during his oral statement on Afghan Resettlement Update of 13 December 2023, Official Report, column 911, whether the existing hotel contracts being extended apply only to new arrivals from Afghanistan.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/298", "label" : {"_value" : "Biography information for Steve McCabe"}
}
, "tablingMemberConstituency" : {"_value" : "Birmingham, Selly Oak"}
, "tablingMemberPrinted" : [{"_value" : "Steve McCabe"}
], "uin" : "10588"}
, {"_about" : "http://data.parliament.uk/resources/1683601", "AnsweringBody" : [{"_value" : "Department for Education"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1683601/answer", "answerText" : {"_value" : "
The government has been successful in delivering the ambition in its International Education Strategy of hosting at least 600,000 students per year, by 2030, for two years running. The department expects that universities will adapt to reduced dependant numbers following the restrictions the government has introduced to control net migration.<\/p>
<\/p>
The department\u2019s offer to international students remains very competitive and the department is committed to ensuring the UK remains a destination of choice for international students from across the globe. International students make a significant economic and cultural contribution to the UK\u2019s higher education (HE) sector, which is good for our universities and delivers growth at home. Those affected by these changes will predominantly be dependants of international students. Students coming to the UK to undertake postgraduate research courses will not be affected by the new restriction on dependents.<\/p>
<\/p>
The Office for Students (OfS), as the regulator for HE in England, has responsibility for monitoring the financial sustainability of registered providers. The department works closely with the OfS to understand the ongoing impacts and changing landscape of financial sustainability in the sector.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3985", "label" : {"_value" : "Biography information for Robert Halfon"}
}
, "answeringMemberConstituency" : {"_value" : "Harlow"}
, "answeringMemberPrinted" : {"_value" : "Robert Halfon"}
, "dateOfAnswer" : {"_value" : "2024-01-24", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-01-24T17:14:50.317Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "60"}
, "answeringDeptShortName" : {"_value" : "Education"}
, "answeringDeptSortName" : {"_value" : "Education"}
, "date" : {"_value" : "2024-01-19", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Overseas Students: Visas"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Education, what assessment she has made of the potential impact of changes to visas for international students and their dependents on the finances of universities.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4471", "label" : {"_value" : "Biography information for Rachael Maskell"}
}
, "tablingMemberConstituency" : {"_value" : "York Central"}
, "tablingMemberPrinted" : [{"_value" : "Rachael Maskell"}
], "uin" : "10625"}
, {"_about" : "http://data.parliament.uk/resources/1683602", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1683602/answer", "answerText" : {"_value" : "
The NHS Business Services Authority publishes official statistics which includes the number of pharmacies opening and closing in each financial year. The following table shows how many pharmacies opened or closed within the last five years:<\/p>
<\/p>
Financial Year<\/p><\/td> | Pharmacies opened<\/p><\/td> | Pharmacies closed<\/p><\/td><\/tr> |
2018/2019<\/p><\/td> | 220<\/p><\/td> | 347<\/p><\/td><\/tr> |
2019/2020<\/p><\/td> | 239<\/p><\/td> | 405<\/p><\/td><\/tr> |
2020/2021<\/p><\/td> | 236<\/p><\/td> | 451<\/p><\/td><\/tr> |
2021/2022<\/p><\/td> | 308<\/p><\/td> | 418<\/p><\/td><\/tr> |
2022/2023<\/p><\/td> | 297<\/p><\/td> | 388<\/p><\/td><\/tr><\/tbody><\/table> <\/p> Community pharmacies are private businesses that receive funding to provide pharmaceutical services for the National Health Service. The decision to close, divest or consolidate is a commercial decision made by the business owner. The Department is monitoring changes to the market closely. Access remains good, with 80% of people in England living within a 20 minutes\u2019 walk from a local pharmacy, and with twice as many pharmacies in deprived areas.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4117", "label" : {"_value" : "Biography information for Andrea Leadsom"}
}
, "answeringMemberConstituency" : {"_value" : "South Northamptonshire"}
, "answeringMemberPrinted" : {"_value" : "Andrea Leadsom"}
, "dateOfAnswer" : {"_value" : "2024-01-29", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "10631"}
, {"_value" : "9432"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-01-29T15:45:06.52Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-01-19", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pharmacy: Closures"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how many community pharmacies have closed in each of the last 5 years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4471", "label" : {"_value" : "Biography information for Rachael Maskell"}
}
, "tablingMemberConstituency" : {"_value" : "York Central"}
, "tablingMemberPrinted" : [{"_value" : "Rachael Maskell"}
], "uin" : "10626"}
, {"_about" : "http://data.parliament.uk/resources/1683603", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1683603/answer", "answerText" : {"_value" : " The future of artificial intelligence (AI) technology and its potential benefits are exciting. We have already made great strides in this area and a number of projects are already underway, all with the aim of accelerating the safe, ethical, and effective use of AI in health and care. For example, we have invested £123 million to test and evaluate AI technologies in crucial areas that cause the most harm to health and the economy, such as strokes and lung cancer.<\/p> The Department has not yet made an assessment of the potential merits of using AI to undertake evaluations of the compatibility, necessity, and other pharmaceutical checks, for medication. However, we will continue to explore where AI could be deployed across health and care systems to transform patient experience and improve health outcomes.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"}
}
, "answeringMemberConstituency" : {"_value" : "Pendle"}
, "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"}
, "dateOfAnswer" : {"_value" : "2024-01-26", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-01-26T15:44:42.87Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-01-19", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pharmacy: Artificial Intelligence"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential merits of using artificial intelligence to undertake (a) assessments of medication for (i) compatibility and (ii) necessity and (b) other pharmaceutical checks.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4471", "label" : {"_value" : "Biography information for Rachael Maskell"}
}
, "tablingMemberConstituency" : {"_value" : "York Central"}
, "tablingMemberPrinted" : [{"_value" : "Rachael Maskell"}
], "uin" : "10627"}
, {"_about" : "http://data.parliament.uk/resources/1683604", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1683604/answer", "answerText" : {"_value" : " Our assessment is that allowing pharmacists to take local action to alter prescriptions and supply an alternative without the full oversight of supply issues that the Department has, could have the effect of creating a knock-on shortage of the alternative and could thereby have the potential to exacerbate rather than mitigate supply problems. Furthermore, pharmacies will not know the reasons why a medicine has been prescribed, and in what particular way.<\/p> However, Serious Shortage Protocols (SSPs) enable community pharmacists to supply a specified medicine or device in accordance with a protocol rather than a prescription, with the patient\u2019s consent, and without needing to seek authorisation from the prescriber. SSPs are an additional tool that have been used in recent years to manage and mitigate medicine and medical devices shortages. SSPs are not introduced unless sufficient supplies of the alternative product to be supplied in accordance with the SSP are available to support the market.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4117", "label" : {"_value" : "Biography information for Andrea Leadsom"}
}
, "answeringMemberConstituency" : {"_value" : "South Northamptonshire"}
, "answeringMemberPrinted" : {"_value" : "Andrea Leadsom"}
, "dateOfAnswer" : {"_value" : "2024-01-29", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-01-29T13:29:00.323Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-01-19", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Prescription Drugs: Pharmacy\n"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of allowing pharmacists to prescribe alternative medications if those prescribed by a GP are not available without referring back to the GP.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4471", "label" : {"_value" : "Biography information for Rachael Maskell"}
}
, "tablingMemberConstituency" : {"_value" : "York Central"}
, "tablingMemberPrinted" : [{"_value" : "Rachael Maskell"}
], "uin" : "10628"}
, {"_about" : "http://data.parliament.uk/resources/1683605", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1683605/answer", "answerText" : {"_value" : " There are approximately 14,000 licensed medicines and the overwhelming majority are in good supply. However, the medicine supply chain is highly regulated, complex, and global and supply disruption is a common issue which affects countries all around the world.<\/p> There are several reasons why supply can be disrupted, including manufacturing difficulties, regulatory non-compliance, access to raw materials, sudden demand spikes or distribution issues. Supply issues are driven by a range of factors, many of which are non-specific to the United Kingdom.<\/p> Whilst we cannot always prevent supply issues from occurring, the Department has a range of well-established processes and tools to manage them when they arise and help mitigate risks to patients. We work closely with industry, the National Health Service, and others to develop bespoke mitigation plans, which are tailored to each issue, to help ensure patients continue to have access to the medicines they need.<\/p> In some cases, an alternative supplier will be able to plug the gap with the exact same medicine. In others, patients will need to return to their clinician for review and consideration of the best treatment plan for them, for example switching to a different medicine. The team routinely shares up to date information about supply issues, for healthcare professionals, via an online Medicine Supply Tool, which is hosted by the Specialist Pharmacy Service.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"}
}
, "answeringMemberConstituency" : {"_value" : "Pendle"}
, "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"}
, "dateOfAnswer" : {"_value" : "2024-01-29", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "10630"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-01-29T16:58:22.347Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-01-19", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Drugs\n"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, for what reason there are medication shortages in the NHS; and if she will have discussions with the pharmaceutical industry on improving the supply.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4471", "label" : {"_value" : "Biography information for Rachael Maskell"}
}
, "tablingMemberConstituency" : {"_value" : "York Central"}
, "tablingMemberPrinted" : [{"_value" : "Rachael Maskell"}
], "uin" : "10629"}
], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&max-ddpModified.=2024-01-22T18%3A15%3A13.067Z&min-ddpCreated=2023-03-23T17%3A41%3A18.570Z&min-ddpModified.=2023-11-08T20%3A16%3A31.022Z", "page" : 0, "startIndex" : 1, "totalResults" : 12536, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}
|